Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Expert Opinion on Emerging Drugs|December 21, 2018
Emerging drugs for EGFR-mutated non-small cell lung cancerVineeth Sukrithan, Lei Deng, Alexander Barbaro, et al.Current Problems in Cancer|July 18, 2024
Management of metastatic pheochromocytomas and paragangliomas: when and whatVineeth Sukrithan, Kimberly Perez, Neeta Pandit-Taskar, et al.Endocrine Oncology (Bristol, England)|July 12, 2023
Kinase inhibitors in thyroid cancersVineeth Sukrithan, Prachi Jain, Manisha H Shah, et al.Journal of Investigative Medicine High Impact Case Reports|June 22, 2017
Pancreatic Cancer Heralded by Worsening Glycemic Control: A Report of Two CasesDimpi Desai, Devika Rao, Vineeth Sukrithan, et al.Expert Opinion on Emerging Drugs|April 26, 2021
Emerging drugs for the treatment of adrenocortical carcinomaVineeth Sukrithan, Marium Husain, Lawrence Kirschner, et al.Academic Radiology|April 27, 2023
Clinical Outcomes of DEB-TACE in Hepatic Metastatic Neuroendocrine Tumors: A 5-Year Single-Institutional ExperienceMina S Makary, Luis E Regalado, Jonathan Alexander, et al.American Journal of Clinical Oncology|November 26, 2019
Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non-Small Cell Lung CancerVineeth Sukrithan, Alexander Barbaro, Adel Chergui, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 17, 2019
Implementation of a Low-Cost Quality Improvement Intervention Increases Adherence to Cancer Screening Guidelines and Reduces Healthcare Costs at a University Medical CenterAlejandro Recio-Boiles, Michael Karass, Jose N Galeas, et al.Endocrine Oncology (Bristol, England)|July 11, 2025
Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATEEleonora Pelle, Taymeyah Al-Toubah, Ghassan El-Haddad, et al.Thyroid : Official Journal of the American Thyroid Association|May 18, 2022
An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid CarcinomaAlycia Hatashima, Brianna Archambeau, Heather Armbruster, et al.Pageof 4